相似文献
1
Neurodegenerative Diseases: Molecular Mechanisms and Therapies.
Int J Mol Sci. 2023 Sep 6;24(18):13721. doi: 10.3390/ijms241813721.
2
Neurodegenerative Disease: From Molecular Basis to Therapy.
Int J Mol Sci. 2024 Jan 12;25(2):967. doi: 10.3390/ijms25020967.
3
Gene transfer into the central and peripheral nervous system: applications for the treatment of neurodegenerative diseases and peripheral neuropathies.
Biotechnol Genet Eng Rev. 2003;20:49-76. doi: 10.1080/02648725.2003.10648037.
4
Neurons and mechanisms of neuronal death in neurodegenerative diseases: a brief review.
Lab Anim Sci. 1999 Aug;49(4):358-62.
5
The production and use of cells as therapeutic agents in neurodegenerative diseases.
Lancet Neurol. 2003 Jul;2(7):417-24. doi: 10.1016/s1474-4422(03)00437-x.
6
Neurodegenerative Diseases: From Molecular Basis to Therapy.
Int J Mol Sci. 2022 Oct 25;23(21):12854. doi: 10.3390/ijms232112854.
7
Mesenchymal Stem Cells: A Potential Therapeutic Strategy for Neurodegenerative Diseases.
Eur Neurol. 2020;83(3):235-241. doi: 10.1159/000509268. Epub 2020 Jul 20.
8
Adrenomedullin, a Novel Target for Neurodegenerative Diseases.
Mol Neurobiol. 2018 Dec;55(12):8799-8814. doi: 10.1007/s12035-018-1031-y. Epub 2018 Mar 29.
9
Human Pluripotent Stem Cells in Neurodegenerative Diseases: Potentials, Advances and Limitations.
Curr Stem Cell Res Ther. 2020;15(2):102-110. doi: 10.2174/1574888X14666190823142911.
10
Potentials of ES cell therapy in neurodegenerative diseases.
Curr Pharm Des. 2008;14(36):3873-9. doi: 10.2174/138161208786898617.
引用本文的文献
1
Harnessing nanotechnology for stem-cell therapies: revolutionizing neurodegenerative disorder treatments - a state-of-the-art update.
Front Pharmacol. 2025 Jul 23;16:1630475. doi: 10.3389/fphar.2025.1630475. eCollection 2025.
2
Potential Roles of Natural Antioxidants in Modulating Neurodegenerative Disease Pathways.
Mol Neurobiol. 2025 Apr 9. doi: 10.1007/s12035-025-04874-w.
3
Application of Network Pharmacology in the Treatment of Neurodegenerative Diseases with Traditional Chinese Medicine.
Planta Med. 2025 Apr;91(5):226-237. doi: 10.1055/a-2512-8928. Epub 2025 Jan 8.
本文引用的文献
1
Molecular Mechanisms Underlying Chronic and Degenerative Diseases.
Int J Mol Sci. 2023 Aug 7;24(15):12507. doi: 10.3390/ijms241512507.
2
α-Synuclein Strains and Their Relevance to Parkinson's Disease, Multiple System Atrophy, and Dementia with Lewy Bodies.
Int J Mol Sci. 2023 Jul 28;24(15):12134. doi: 10.3390/ijms241512134.
3
Neurodegenerative Disease Associated Pathways in the Brains of Triple Transgenic Alzheimer's Model Mice Are Reversed Following Two Weeks of Peripheral Administration of Fasudil.
Int J Mol Sci. 2023 Jul 7;24(13):11219. doi: 10.3390/ijms241311219.
4
Role of Exosomes in the Pathogenesis and Theranostic of Alzheimer's Disease and Parkinson's Disease.
Int J Mol Sci. 2023 Jul 4;24(13):11054. doi: 10.3390/ijms241311054.
5
Parkin Precipitates on Mitochondria via Aggregation and Autoubiquitination.
Int J Mol Sci. 2023 May 19;24(10):9027. doi: 10.3390/ijms24109027.
6
Effect of Electric Field on α-Synuclein Fibrils: Revealed by Molecular Dynamics Simulations.
Int J Mol Sci. 2023 Mar 28;24(7):6312. doi: 10.3390/ijms24076312.
7
Impaired Autophagy in Krabbe Disease: The Role of BCL2 and Beclin-1 Phosphorylation.
Int J Mol Sci. 2023 Mar 22;24(6):5984. doi: 10.3390/ijms24065984.
8
Overexpression of a Novel Noxo1 Mutant Increases Ros Production and Noxo1 Relocalisation.
Int J Mol Sci. 2023 Feb 28;24(5):4663. doi: 10.3390/ijms24054663.
9
Experimental Models of In Vitro Blood-Brain Barrier for CNS Drug Delivery: An Evolutionary Perspective.
Int J Mol Sci. 2023 Jan 31;24(3):2710. doi: 10.3390/ijms24032710.
10
Longevity-Associated Variant of BPIFB4 Confers Neuroprotection in the STHdh Cell Model of Huntington Disease.
Int J Mol Sci. 2022 Dec 5;23(23):15313. doi: 10.3390/ijms232315313.
Zotero 插件